Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Torgrim Tandstad

Showing results (31-40 of 62) with videos related to

Pageof 7
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 13, 2021
Testicular Cancer in the Cisplatin Era: Causes of Death and Mortality Rates in a Population-Based CohortRagnhild Hellesnes, Tor Åge Myklebust, Sophie D Fosså, et al.
International Journal of Cancer|October 10, 2019
Continuing increased risk of second cancer in long-term testicular cancer survivors after treatment in the cisplatin eraRagnhild Hellesnes, Øivind Kvammen, Tor Å Myklebust, et al.
Urologic Oncology|August 16, 2016
Associations between long-term serum platinum and neurotoxicity and ototoxicity, endocrine gonadal function, and cardiovascular disease in testicular cancer survivorsLine V Hjelle, Roy M Bremnes, Per O M Gundersen, et al.
Journal of Public Health Research|December 31, 2020
Long-term work outcomes and the efficacy of multidisciplinary rehabilitation programs on labor force participation in cancer patients - a protocol for a longitudinal prospective cohort studyHarald K Engan, Line M Oldervoll, Gro F Bertheussen, et al.
European Urology|June 27, 2021
Circulating MicroRNAs, the Next-Generation Serum Biomarkers in Testicular Germ Cell Tumours: A Systematic ReviewRicardo Leão, Maarten Albersen, Leendert H J Looijenga, et al.
Acta Oncologica (Stockholm, Sweden)|May 19, 2018
Long-term serum platinum changes and their association with cisplatin-related late effects in testicular cancer survivorsLine V Hjelle, Per O M Gundersen, Ragnhild Hellesnes, et al.
Scandinavian Journal of Urology|April 13, 2026
Complications and clinical outcomes of retroperitoneal lymph node dissection for testicular cancer in a centralized population-based cohort in Sweden: insights from SWENOTECAAnna Thor, Anna Grenabo Bergdahl, Armin Abniki, et al.
European Urology Open Science|September 15, 2023
Prechemotherapy Not Preorchiectomy Serum Tumor Markers Accurately Identify International Germ Cell Cancer Collaborative Group Prognostic Groups in NonseminomaChristian D Fankhauser, Abolghassem Jandari, Laurence Collette, et al.
The Journal of Urology|July 25, 2024
miR-371a-3p Predicting Viable Tumor in Patients Undergoing Retroperitoneal Lymph Node Dissection for Metastatic Testicular Cancer: The SWENOTECA-MIR StudyAnna Thor, Mette Pernille Myklebust, Anna Grenabo Bergdahl, et al.
British Journal of Cancer|December 21, 2025
High-dose chemotherapy in male germ cell cancer patients-a study by the SWENOTECA groupAnna K Jansson, Gabriella Cohn-Cedermark, Helene F S Negaard, et al.
Pageof 7

Showing results (31-40 of 62) with videos related to

Sort By:
Pageof 7
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 13, 2021
Testicular Cancer in the Cisplatin Era: Causes of Death and Mortality Rates in a Population-Based CohortRagnhild Hellesnes, Tor Åge Myklebust, Sophie D Fosså, et al.
International Journal of Cancer|October 10, 2019
Continuing increased risk of second cancer in long-term testicular cancer survivors after treatment in the cisplatin eraRagnhild Hellesnes, Øivind Kvammen, Tor Å Myklebust, et al.
Urologic Oncology|August 16, 2016
Associations between long-term serum platinum and neurotoxicity and ototoxicity, endocrine gonadal function, and cardiovascular disease in testicular cancer survivorsLine V Hjelle, Roy M Bremnes, Per O M Gundersen, et al.
Journal of Public Health Research|December 31, 2020
Long-term work outcomes and the efficacy of multidisciplinary rehabilitation programs on labor force participation in cancer patients - a protocol for a longitudinal prospective cohort studyHarald K Engan, Line M Oldervoll, Gro F Bertheussen, et al.
European Urology|June 27, 2021
Circulating MicroRNAs, the Next-Generation Serum Biomarkers in Testicular Germ Cell Tumours: A Systematic ReviewRicardo Leão, Maarten Albersen, Leendert H J Looijenga, et al.
Acta Oncologica (Stockholm, Sweden)|May 19, 2018
Long-term serum platinum changes and their association with cisplatin-related late effects in testicular cancer survivorsLine V Hjelle, Per O M Gundersen, Ragnhild Hellesnes, et al.
Scandinavian Journal of Urology|April 13, 2026
Complications and clinical outcomes of retroperitoneal lymph node dissection for testicular cancer in a centralized population-based cohort in Sweden: insights from SWENOTECAAnna Thor, Anna Grenabo Bergdahl, Armin Abniki, et al.
European Urology Open Science|September 15, 2023
Prechemotherapy Not Preorchiectomy Serum Tumor Markers Accurately Identify International Germ Cell Cancer Collaborative Group Prognostic Groups in NonseminomaChristian D Fankhauser, Abolghassem Jandari, Laurence Collette, et al.
The Journal of Urology|July 25, 2024
miR-371a-3p Predicting Viable Tumor in Patients Undergoing Retroperitoneal Lymph Node Dissection for Metastatic Testicular Cancer: The SWENOTECA-MIR StudyAnna Thor, Mette Pernille Myklebust, Anna Grenabo Bergdahl, et al.
British Journal of Cancer|December 21, 2025
High-dose chemotherapy in male germ cell cancer patients-a study by the SWENOTECA groupAnna K Jansson, Gabriella Cohn-Cedermark, Helene F S Negaard, et al.
Pageof 7